Johnson & Johnson Western Hemisphere Excluding US — Percent Change increased by 1080.0% to $0.05 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1533.3%, from $0.00 to $0.05. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates organic growth or market share gains in the region, while a negative percentage signals a contraction or loss of market share.
This metric measures the period-over-period percentage growth or decline in net sales for the Western Hemisphere, exclud...
Comparable to regional organic growth rates or constant currency growth metrics reported by global pharmaceutical and medical device competitors.
jnj_segment_western_hemisphere_excluding_u_s_percent_change| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$0.05 | $0.21 | $0.16 | $0.04 | $0.12 | $0.04 | $0.07 | $0.11 | $0.11 | $0.07 | $0.00 | -$0.02 | -$0.01 | $0.05 |
| QoQ Change | — | +503.9% | -23.8% | -73.9% | +202.4% | -66.9% | +73.2% | +47.9% | +4.8% | -39.1% | -95.5% | -866.7% | +78.3% | >999% |
| YoY Change | — | — | — | +180.4% | -39.8% | -73.9% | +73.2% | -15.3% | — | -5.6% | -97.1% | -120.9% | -107.5% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.